BiggerJT. Antiarrhythmic treatment: An overview. Am J Cardiol1984; 53: 8B–16B.
2.
KennedyHLPescarmoniaJEBouchardRJGoldbergRJ. Coronary artery status of apparently healthy subjects with frequent and complex ventricular ectopy. Ann Intern Med1980; 92: 179–85.
3.
MeinertzTHofmannTKasperW. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol1984; 53: 902–7.
4.
UnverferthDVMagorienRDMoeschbergerMLBakerPBFettersJKLeierCV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol1984; 54: 147–52.
5.
ZatuchniJ. The treatment of congestive heart failure with diuretics and non-diuretic agents. Clin Ther1988; 10: 328–49.
6.
PodridPJ. Treatment of ventricular arrhythmia. Applications and limitations of noninvasive vs invasive approach. Chest1985; 88: 121–8.
7.
MaxwellDJCrawfordDCCurryPVMTynanMJAllanLD. Obstetric importance, diagnosis, and management of fetal tachycardias. Br Med J1988; 297: 107–10.
8.
BraunwaldE. Heart disease. A textbook of cardiovascular medicine. 3rd ed. Philadelphia: WB Saunders, 1988.
9.
DeedwaniaPC. Significance of arrhythmias in congestive heart failure. Postgrad Med1988; 83: 223–34.
10.
ClelandJGFDargieHJ. Arrhythmias, catecholamines and electrolytes. Am J Cardiol1988; 62: 55A–9A.
11.
LownBWolfM. Approaches to sudden death from coronary heart disease. Circulation1971; 44: 130–42.
12.
HinkleLEJrCarverSTStevensM. The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. Am J Cardiol1969; 24: 629–50.
13.
HolmesJKuboSHCodyRJKligfieldMD. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol1985; 55: 146–51.
14.
PackerMGottliebSSBlumMA. Immediate and long-term pathophysiologic mechanisms underlying the queries of sudden cardiac death in patients with congestive heart failure. Am J Med1987; 82 (suppl 3A): 4–10.
15.
ColemanJJVollmerWMBarkerAFSchultzGIBuistAS. Cardiac arrhythmias during combined use of β-adrenergic agonist drugs and theophylline. Chest1986; 90: 45–51.
16.
CohenLKitzesR. Magnesium sulfate and digitalis-toxic arrhythmias. JAMA1983; 249: 2808–10.
17.
LeeWHPackerM. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation1986; 73: 257–67.
18.
SzatalowiczVLArnoldPEChaimovitzCBichetDBerlTSchrierRW. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med1981; 305: 263–6.
19.
ClelandJGFDargieHJRobertsonIRobertsonJISEastBW. Total body electrolyte composition in patients with heart failure: A comparison with normal subjects and patients with untreated hypertension. Br Heart J1987; 58: 230–8.
20.
NordrehaugJEJohannessenKAVon Der LippeG. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation1985; 71: 645–9.
21.
HollifieldJW. Magnesium depletion, diuretics and arrhythmias. Am J Med1987; 82 (suppl 2A): 30–7.
22.
WhangROeiJOWatanabeA. Frequency of hypomagnesemia in hospitalized patients receiving digitalis. Arch Intern Med1985; 145: 655–6.
23.
TzivoniDBanaiSSchugerC. Treatment of torsade de pointes with magnesium sulphate. Circulation1988; 77: 392–7.
24.
BrownJJDaviesDLJohnsonVWLeverAFRobertsonJIS. Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J1970; 80: 329–42.
25.
CohnJNLevineTBFrancisGSGoldsmithS. Neurohumoral control mechanisms in congestive heart failure. Am Heart J1981; 102: 509–14.
26.
PackerM. Neurohormonal interactions and adaptations in congestive heart failure. Circulation1988; 77: 721–80.
27.
ThomasRDMorganDBNewillA. The cause of the raised plasma urea of acute heart failure. Postgrad Med1979; 55: 10–4.
28.
PackerMLeeWHMedinaNYushakMKesslerPD. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med1987; 106: 346–54.
29.
MyerburgRJKesslerKMZamanLFernandezPDeMarchenaECastellanosA. Pharmacologic approaches to management of arrhythmias in patients with cardiomyopathy and heart failure. Am Heart J1987; 114: 1273–9.
30.
BrugadaPWellensHJJ. Arrhythmogenesis of antiarrhythmic drugs. Am J Cardiol1988; 61: 1108–11.
31.
PodridPJMorganrothJ. Aggravation of arrhythmia during drug therapy: Experience with flecainide acetate. Pract Cardiol1985; 11: 55–70.
32.
MeissnerMDKayHRHorowitzLNSpielmanSRGreenspanAMKutalekSP. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Am J Cardiol1988; 61: 1050–5.
33.
GreenblattDR. Digitalis glycosides. In: MillerRRGreenblattDR. Drug effects in hospitalized patients. Experiences of the Boston Collaborative Drug Surveillance Program 1966–1975. New York: John Wiley & Sons, 1976: 36–40.
34.
ProppDAHoganTMattimoreJ. Nausea, dyspnea and heart block in an 86-year-old patient with congestive heart failure. Ann Emerg Med1988; 17: 261–7.
35.
ColePLSmithTW. Use of digoxin-specific Fab fragments in the treatment of digitalis intoxication. Drug Intell Clin Pharm1986; 20: 267–70.
36.
SmithTW. Digitalis. Mechanisms of action and clinical use. N Engl J Med1988; 318: 358–65.
37.
WoosleyRL. Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure. Am Heart J1987; 114: 1280–91.